Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ferdinando Squitieri

Showing results (21-30 of 147) with videos related to

Pageof 15
Sort By:
Mechanisms of Ageing and Development|November 9, 2005
Juvenile Huntington's disease: does a dosage-effect pathogenic mechanism differ from the classical adult disease?Ferdinando Squitieri, Luigi Frati, Andrea Ciarmiello, et al.
Genes|November 11, 2022
Current Diagnostic Methods and Non-Coding RNAs as Possible Biomarkers in Huntington's DiseaseMiguel Pellegrini, Guendalina Bergonzoni, Federica Perrone, et al.
Neural Regeneration Research|January 31, 2020
Emotion recognition and inhibitory control in manifest and pre-manifest Huntington's disease: evidence from a new Stroop taskThomas Hunefeldt, Sabrina Maffi, Simone Migliore, et al.
International Journal of Molecular Sciences|August 6, 2020
Mitochondrial Respiration Changes in R6/2 Huntington's Disease Model Mice during Aging in a Brain Region Specific MannerJohannes Burtscher, Alba Di Pardo, Vittorio Maglione, et al.
The International Journal of Neuroscience|November 28, 2018
Effects of stimulus-related variables on mental states recognition in Huntington's diseaseMarta Olivetti Belardinelli, Thomas Huenefeldt, Sabrina Maffi, et al.
Journal of Huntington'S Disease|September 24, 2015
Antidopaminergic Medication is Associated with More Rapidly Progressive Huntington's DiseaseJoakim Tedroff, Susanna Waters, Roger A Barker, et al.
Parkinsonism & Related Disorders|September 12, 2022
Early liver steatosis in children with pediatric Huntington disease and highly expanded CAG mutationsFerdinando Squitieri, Lidia Monti, Federica Graziola, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|January 8, 2019
CM-Pf deep brain stimulation and the long term management of motor and psychiatric symptoms in a case of Tourette syndromeMassimo Marano, Simone Migliore, Ferdinando Squitieri, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|November 17, 2004
New Huntington disease mutation arising from a paternal CAG34 allele showing somatic length variation in serially passaged lymphoblastsMilena Cannella, Vittorio Maglione, Tiziana Martino, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 25, 2012
18F-FDG PET uptake in the pre-Huntington disease caudate affects the time-to-onset independently of CAG expansion sizeAndrea Ciarmiello, Giampiero Giovacchini, Sara Orobello, et al.
Pageof 15

Showing results (21-30 of 147) with videos related to

Sort By:
Pageof 15
Mechanisms of Ageing and Development|November 9, 2005
Juvenile Huntington's disease: does a dosage-effect pathogenic mechanism differ from the classical adult disease?Ferdinando Squitieri, Luigi Frati, Andrea Ciarmiello, et al.
Genes|November 11, 2022
Current Diagnostic Methods and Non-Coding RNAs as Possible Biomarkers in Huntington's DiseaseMiguel Pellegrini, Guendalina Bergonzoni, Federica Perrone, et al.
Neural Regeneration Research|January 31, 2020
Emotion recognition and inhibitory control in manifest and pre-manifest Huntington's disease: evidence from a new Stroop taskThomas Hunefeldt, Sabrina Maffi, Simone Migliore, et al.
International Journal of Molecular Sciences|August 6, 2020
Mitochondrial Respiration Changes in R6/2 Huntington's Disease Model Mice during Aging in a Brain Region Specific MannerJohannes Burtscher, Alba Di Pardo, Vittorio Maglione, et al.
The International Journal of Neuroscience|November 28, 2018
Effects of stimulus-related variables on mental states recognition in Huntington's diseaseMarta Olivetti Belardinelli, Thomas Huenefeldt, Sabrina Maffi, et al.
Journal of Huntington'S Disease|September 24, 2015
Antidopaminergic Medication is Associated with More Rapidly Progressive Huntington's DiseaseJoakim Tedroff, Susanna Waters, Roger A Barker, et al.
Parkinsonism & Related Disorders|September 12, 2022
Early liver steatosis in children with pediatric Huntington disease and highly expanded CAG mutationsFerdinando Squitieri, Lidia Monti, Federica Graziola, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|January 8, 2019
CM-Pf deep brain stimulation and the long term management of motor and psychiatric symptoms in a case of Tourette syndromeMassimo Marano, Simone Migliore, Ferdinando Squitieri, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|November 17, 2004
New Huntington disease mutation arising from a paternal CAG34 allele showing somatic length variation in serially passaged lymphoblastsMilena Cannella, Vittorio Maglione, Tiziana Martino, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 25, 2012
18F-FDG PET uptake in the pre-Huntington disease caudate affects the time-to-onset independently of CAG expansion sizeAndrea Ciarmiello, Giampiero Giovacchini, Sara Orobello, et al.
Pageof 15